Copertina

A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Eloise Neumann, Thomas J. Jackson, Jessica E. Morgan, Robert Phillips, Jessica Bate
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pediatric Blood & Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Correction to “A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children”
Pubblicazione: (2026)

Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus
di: Negar Shavandi, et al.
Pubblicazione: (2026)

Sodium Thiosulfate for Ototoxicity Prevention: A National Review of UK Practice
di: Jonathan Abrams, et al.
Pubblicazione: (2025)

“That's All Anyone Needs Really, Support”: A Content Analysis of Retinoblastoma Survivors’ Psychosocial Support Needs
di: Nicola O'Donnell, et al.
Pubblicazione: (2025)

The Performance of the Australian–UK–Swiss Clinical Decision Rule for Febrile Neutropenia in Children and Young Adults With Bone and Soft Tissue Sarcomas
di: Arun K. Mahapatra, et al.
Pubblicazione: (2025)

A systematic review of combined surgery and brachytherapy approaches for children and young people with relapsed and refractory rhabdomyosarcoma (Local‐REFoRMS)
di: Euan Ballantyne, et al.
Pubblicazione: (2024)

Chemotherapy–Surgery Interval Effects on Tumor Necrosis and Outcome in Children and Young Adults With Osteosarcoma
di: Rachel B. Mersfelder, et al.
Pubblicazione: (2024)

Vomiting despite adherence to guidelines: Suboptimal control of vomiting in pediatric cancer patients
di: Rotem Fishel Ben‐Kenan, et al.
Pubblicazione: (2024)

Photobiomodulation Therapy in the Prevention of Chemotherapy Induced Oral Mucositis in Children with Acute Myeloid Leukemia: A Randomized, Double‐blind, Clinical trial
di: Reem E. Elkady, et al.
Pubblicazione: (2024)

Safety and Efficacy of Romiplostim in Maintaining Chemotherapy Interval and Dose Intensity in Pediatric Patients With Solid Tumors and Chemotherapy‐Induced Thrombocytopenia
di: Erica Tonti, et al.
Pubblicazione: (2026)

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience
di: Thomas J. Jackson, et al.
Pubblicazione: (2026)

Reduced‐Intensity Chemotherapy With Immunotherapy for Children With Down Syndrome and B‐Cell Acute Lymphoblastic Leukemia
di: Ashley C. Holland, et al.
Pubblicazione: (2025)

The Dangerousness of a Devilled Egg
di: Robert Stephen Phillips
Pubblicazione: (2025)

MEK Inhibition With Trametinib for the treatment of MAP2K1‐Mutated Rosai–Dorfman–Destombes Disease Arising from the Nasopharynx in a Paediatric Patient
di: Claire Cuerden, et al.
Pubblicazione: (2025)

Melanoma of the Choroid and Ciliary Body in Children: Remission of Metastatic Melanoma of the Choroid After Treatment With Chemotherapy and Immune Checkpoint Inhibition
di: Pia Tüller, et al.
Pubblicazione: (2025)

Use of Autologous Umbilical Cord Blood in Neonatal Cardiac Surgery: A European Survey of Current Practices and Perceptions
di: Sonia Garcés‐Sánchez, et al.
Pubblicazione: (2025)

Current Treatment Strategies and Supportive Care Practices in the Care of Children and Adolescents With Mature B‐Cell Non‐Hodgkin Lymphoma: A Survey of Children's Oncology Group Institutions
di: Jennifer A. Belsky, et al.
Pubblicazione: (2025)

Clinical Practice Guideline for the Management of Communication and Swallowing in Children Diagnosed With Childhood Brain Tumor or Leukemia
di: Kimberley M. Docking, et al.
Pubblicazione: (2025)

European Standard Clinical Practice Recommendations for Cutaneous Melanoma in Children and Adolescents
di: Luca Bergamaschi, et al.
Pubblicazione: (2026)

Family Perspectives on Pediatric Complementary and Integrative Medicine Practices in Pediatric Hematology and Oncology
di: Alexia Kessler, et al.
Pubblicazione: (2026)

Real‐World Use of Avatrombopag in Children and Adolescents With Immune Thrombocytopenia
di: Emily M. Harris, et al.
Pubblicazione: (2025)

Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma
di: Aseel Bzour, et al.
Pubblicazione: (2025)

Outcome of Premature Infants Treated With Chemotherapy for Neuroblastoma in France
di: Dana Al Khalifa, et al.
Pubblicazione: (2025)

Outcomes Based on Histological Tumor Necrosis and Predictive Clinical and Laboratory Parameters for Necrosis in Children With Osteosarcoma Treated on a Non‐High Dose Methotrexate‐Based Chemotherapy Backbone
di: Badira Cheriyalinkal Parambil, et al.
Pubblicazione: (2024)

Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial
di: Nirali N. Shah, et al.
Pubblicazione: (2025)

Rib Ewing Sarcomas in Children and Young Adults: A Large National Retrospective Series
di: Audrey Claren, et al.
Pubblicazione: (2025)

Prevalence and Trajectory of Household Material Hardship Among Children With Advanced Cancer
di: Sarah Wright, et al.
Pubblicazione: (2026)

Dabrafenib as a Therapeutic Option for Chemotherapy‐Refractory Pediatric Juvenile Xanthogranuloma
di: Mengxuan Wang, et al.
Pubblicazione: (2025)

Pulmonary Consequences of Surgical Treatment in Children's Primary Lung Tumors: A National Retrospective Study
di: Flavie Godard, et al.
Pubblicazione: (2025)

Clinical Practice Patterns for Discussing Hydroxyurea Initiation With Families of Children With Sickle Cell Disease
di: Aimee K. Hildenbrand, et al.
Pubblicazione: (2026)

Survival for Children Diagnosed With Wilms Tumour (2012–2022) Registered in the UK and Ireland Improving Population Outcomes for Renal Tumours of Childhood (IMPORT) Study
di: Naomi Ssenyonga, et al.
Pubblicazione: (2026)

Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease
di: Jill S. Menell, et al.
Pubblicazione: (2025)

Real‐World Experience Using Sodium Thiosulfate Pentahydrate Off‐Label for Cisplatin Otoprotection in Children, Adolescents, and Young Adults
di: Julie Ma, et al.
Pubblicazione: (2025)

Two Surveys, 16 Years Apart: Comparing Traditional and Complementary Medicine Use by Children With Cancer in Jordan
di: Murad Sawalha, et al.
Pubblicazione: (2025)

Management of Philadelphia Chromosome‐Positive B‐Lymphoblastic Leukemia Diagnosed in an Infant
di: Jessica A. O. Zimmerman, et al.
Pubblicazione: (2025)

Feasibility of an Intravenous Home Chemotherapy Intervention With Low‐Dose Cytarabine Administered by Parents (INTACTatHome)
di: Louise Ingerslev Roug, et al.
Pubblicazione: (2025)

Tandem High‐Dose Chemotherapy and Autologous Stem Cell Transplantation for Osteosarcoma With Initial Pulmonary Metastases
di: Hyun Jin Park, et al.
Pubblicazione: (2025)

How We Approach the Integration of Psychological Services in the Care of Children With Cancer Predisposition Syndromes
di: Joan W. Hanania, et al.
Pubblicazione: (2025)

Hypoalbuminemia and Nutritional Status in Children With Cancer
di: Thomas W. McLean, et al.
Pubblicazione: (2024)

Use of Oral Metformin Therapy for Therapy‐Induced Hyperglycemia in Pediatric Patients With Acute Lymphoblastic Leukemia
di: Ankita Chakraborty, et al.
Pubblicazione: (2026)